rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jonathan Poole

Director

Company insider

Files Form 4 as: Director, ACADIA Pharmaceuticals; CFO, Evelo Biosciences; Chief Financial Officer, Genocea Biosciences.

Every Form 4 they filed

In numbers

Trades disclosed
34
Buys
2
Sells
2
Bought
$39K
Sold
$310K
Companies
3
Companies where not an officer
1
First trade
7 Apr 2014
Last trade
29 May 2026
Last filed
1 Jun 2026

Companies traded

Where they are an officer
Evelo BiosciencesOfficer · last 28 Jan 20200 buys · 0 sells
Genocea BiosciencesOfficer · last 8 Feb 20182 buys · 2 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ACAD ACADIA PharmaceuticalsDirector · Pharmaceuticals · last 29 May 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
29 May 2026filed 1 Jun 2026ACAD ACADIA PharmaceuticalsPharmaceuticalsSEC FORM 4 Code M—2,010filing
29 May 2026filed 1 Jun 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—2,010 at $0.00filing
29 May 2026filed 1 Jun 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—16,004 at $0.00filing
29 May 2026filed 1 Jun 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—2,010 at $0.00filing
29 May 2026filed 1 Jun 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—16,004 at $0.00filing
29 May 2026filed 1 Jun 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—9,311 at $0.00filing
29 May 2026filed 1 Jun 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—9,311 at $0.00filing
29 May 2026filed 1 Jun 2026ACAD ACADIA PharmaceuticalsPharmaceuticalsSEC FORM 4 Code M—2,010filing
3 Mar 2026filed 20 Mar 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,482 at $0.00filing
3 Mar 2026filed 20 Mar 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—3,565 at $0.00filing
3 Mar 2026filed 20 Mar 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—4,218 at $0.00filing
3 Mar 2026filed 20 Mar 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,482 at $0.00filing
3 Mar 2026filed 20 Mar 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—3,565 at $0.00filing
3 Mar 2026filed 20 Mar 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—4,218 at $0.00filing
3 Mar 2026filed 20 Mar 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—2,010 at $0.00filing
3 Mar 2026filed 20 Mar 2026ACAD ACADIA Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—2,010 at $0.00filing
28 Jan 2020filed 30 Jan 2020Evelo Biosciencesoption or derivativeSEC FORM 4 Code A—106,000 at $0.00filing
28 Jan 2020filed 30 Jan 2020Evelo Biosciencesoption or derivativeSEC FORM 4 Code A—48,000 at $0.00filing
14 Jan 2019filed 16 Jan 2019Evelo Biosciencesoption or derivativeSEC FORM 4 Code A—100,000 at $0.00filing
8 May 2018filed 10 May 2018Evelo Biosciencesoption or derivativeSEC FORM 4 Code A—71,497 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.